Tyzepa Injection 5 mg/0.5 ml contains Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is designed for the treatment of type 2 diabetes mellitus, particularly in patients who require better glycemic control along with weight management. Tirzepatide represents an advanced therapeutic option that leverages the complementary effects of GIP and GLP-1 pathways to improve blood glucose regulation.

Tyzepa helps patients achieve optimal glycemic control by enhancing insulin secretion in response to meals, reducing glucagon release, and promoting satiety, which can support weight reduction. Its once-weekly subcutaneous administration improves treatment adherence while providing significant metabolic benefits.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Tirzepatide 5 mg per 0.5 ml prefilled injection

Mechanism of Action

Tirzepatide is a dual incretin receptor agonist, acting on both GIP and GLP-1 receptors to regulate glucose homeostasis:

1. GIP receptor activation – Enhances glucose-dependent insulin secretion from pancreatic beta cells and supports lipid metabolism.

2. GLP-1 receptor activation – Stimulates insulin release, inhibits glucagon secretion, slows gastric emptying, and promotes satiety.

3. Combined effect – Reduces postprandial and fasting blood glucose levels while supporting weight management through reduced appetite and improved metabolic function.

This dual mechanism provides superior glycemic control compared to single incretin-based therapies and contributes to cardiovascular and metabolic benefits in type 2 diabetes patients.

Indications

Tyzepa Injection 5 mg/0.5 ml is indicated for:

• Type 2 diabetes mellitus – as monotherapy or in combination with other antidiabetic agents to improve glycemic control

• Weight management – in overweight or obese patients with type 2 diabetes, as part of a comprehensive lifestyle intervention

• Adjunct therapy – for patients inadequately controlled with diet, exercise, or other glucose-lowering medications

It is intended for subcutaneous administration under the guidance of a healthcare professional.

Dosage and Administration

• Recommended dose: 5 mg once weekly, administered subcutaneously in the abdomen, thigh, or upper arm.

• Dosage may be adjusted by the physician based on efficacy and tolerability, often starting at a lower dose and titrating upward.

• Rotate injection sites with each dose to reduce the risk of local reactions.

• Administer at the same time each week for optimal glycemic control.

• Patients should monitor blood glucose regularly and maintain lifestyle measures including diet and exercise.

Benefits

• Effective glycemic control in type 2 diabetes

• Reduces postprandial and fasting blood sugar levels

• Supports weight loss through appetite suppression and improved metabolism

• Convenient once-weekly dosing for improved adherence

• Potential cardiovascular and metabolic benefits beyond glucose control

Precautions

• Use cautiously in patients with a history of pancreatitis or severe gastrointestinal disease.

• Not recommended for type 1 diabetes or diabetic ketoacidosis.

• Monitor for signs of hypoglycemia when used with insulin or sulfonylureas.

• Avoid in patients with known hypersensitivity to Tirzepatide or any component of the injection.

• Pregnancy and breastfeeding: Use only if benefits outweigh potential risks.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Nausea, vomiting, or diarrhea

• Decreased appetite

• Injection site reactions: redness, itching, or swelling

• Mild headache or fatigue

Rare but serious side effects:

• Pancreatitis

• Severe gastrointestinal disturbances

• Allergic reactions

Storage

• Store in a refrigerator at 2–8°C

• Do not freeze

• Keep the prefilled pen in its original packaging to protect from light

• Keep out of reach of children

Tyzepa Injection 5 mg/0.5 ml offers a modern, dual-action incretin therapy for type 2 diabetes, providing effective glycemic control, weight management, and improved metabolic outcomes under medical supervision.